Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.5.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Operating activities:    
Consolidated net income $ 235.4 $ 202.1
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Impairment of cost method investment 0.0 14.8
Depreciation and amortization 124.7 100.8
Stock-based compensation expense 22.2 24.5
Excess tax benefits from stock-based compensation plans (20.0) (17.1)
Deferred income taxes 2.6 (18.6)
Changes in assets and liabilities, excluding effects of acquisitions:    
Accounts receivable, net (42.5) (34.8)
Prepaid expenses and other current assets 12.4 2.7
Other assets (4.9) 4.4
Current liabilities, excluding debt (65.7) 9.4
Other long-term liabilities, excluding debt 15.3 1.4
Cash provided by operating activities 279.5 289.6
Investing activities:    
Capital expenditures (82.8) (55.2)
Acquisitions, net of cash acquired (1,727.8) (4.4)
Economic hedges (10.8) 0.0
Investment in unconsolidated affiliates, net 0.0 (0.1)
Cash used in investing activities (1,821.4) (59.7)
Financing activities:    
Net short-term borrowings (repayments) 207.5 (45.2)
Payments on long-term debt (210.0) 0.0
Borrowings on long-term debt 1,574.7 0.0
Treasury stock purchases 0.0 (182.2)
Dividends paid to Equifax shareholders (78.6) (69.0)
Dividends paid to noncontrolling interests (5.6) (6.0)
Proceeds from exercise of stock options 15.7 17.2
Excess tax benefits from stock-based compensation plans 20.0 17.1
Debt issuance costs (5.5) 0.0
Cash provided by (used in) financing activities 1,518.2 (268.1)
Effect of foreign currency exchange rates on cash and cash equivalents 27.2 (5.9)
Increase (decrease) in cash and cash equivalents 3.5 (44.1)
Cash and cash equivalents, beginning of period 93.3 128.3
Cash and cash equivalents, end of period $ 96.8 $ 84.2